| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4030393 | Ophthalmology | 2006 | 10 Pages |
Abstract
Oral ruboxistaurin treatment reduced vision loss, need for laser treatment, and macular edema progression, while increasing occurrence of visual improvement in patients with nonproliferative retinopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
PKC-DRS2 Group PKC-DRS2 Group,